MedPath
FDA Approval

ARSENIC TRIOXIDE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
May 4, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Arsenic trioxide(2 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

MSN Laboratories Private Limited

Orbicular Pharmaceutical Technologies Private Limited

650786952

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ARSENIC TRIOXIDE

Product Details

NDC Product Code
81607-006
Application Number
ANDA217413
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
May 4, 2023
Code: S7V92P67HOClass: ACTIBQuantity: 2 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT

ARSENIC TRIOXIDE

Product Details

NDC Product Code
81607-005
Application Number
ANDA217413
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
May 4, 2023
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: S7V92P67HOClass: ACTIBQuantity: 1 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath